Galectin Therapeutics CEO Harold Shlevin's 2019 pay falls 25% to $1.3M
Galectin Therapeutics reports 2019 executive compensation
By ExecPay News
Published: October 19, 2020
Galectin Therapeutics reported fiscal year 2019 executive compensation information on October 19, 2020.
In 2019, two executives at Galectin Therapeutics received on average a compensation package of $1M, a 30% decrease compared to previous year.
Average pay of disclosed executives at Galectin Therapeutics
Harold H. Shlevin, Chief Executive Officer, received $1.3M in total, which decreased by 25% compared to 2018. 38% of Shlevin's compensation, or $500K, was in salary. Shlevin also received $466K in bonus, $268K in option awards, as well as $73K in other compensation.
Jack W. Callicutt, Chief Financial Officer, received a compensation package of $778K, which decreased by 39% compared to previous year. 37% of the compensation package, or $285K, was in salary.
Related executives
You may also like
Source: SEC filing on October 19, 2020.